Therapeutics
Showing 1 - 25 of 8,305
Clinical Audit, Quality Improvement Trial in Vancouver (Portrait, Therapeutics Letter)
Completed
- Clinical Audit
- Quality Improvement
- Portrait
- Therapeutics Letter
-
Vancouver, British Columbia, CanadaTherapeutics Initiative - Dept of Anesthesiology, Pharmacology &
Apr 4, 2023
Migraine, Episodic Migraine, Headache Trial in New York (ReMMi-D Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- ReMMi-D Digital Therapeutic
-
New York, New YorkClick Therapeutics
May 10, 2023
Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- Click Digital Therapeutic
-
New York, New YorkClick Therapeutics
Aug 15, 2023
Mild Cognitive Impairment Trial in Milan (virtual reality non-embodied, virtual reality embodied, treatment as usual)
Not yet recruiting
- Mild Cognitive Impairment
- virtual reality non-embodied
- +2 more
-
Milan, Lombardia, ItalyCosimo Tuena
Oct 5, 2023
Schizophrenia Trial in New York (Digital Therapeutic)
Recruiting
- Schizophrenia
- Digital Therapeutic
-
New York, New YorkClick Therapeutics
Apr 20, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ublituximab, Umbralisib, Venetoclax)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +49 more
Jan 20, 2023
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Huntsville, Alabama
- +51 more
Dec 21, 2022
Pruritus, Atopic Dermatitis Trial (difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream)
Recruiting
- Pruritus
- Atopic Dermatitis
- difelikefalin 0.25 mg
- +4 more
-
Scottsdale, Arizona
- +36 more
Dec 21, 2022
Mild Cognitive Impairment Trial in Incheon (ET-101, Sham Device)
Recruiting
- Mild Cognitive Impairment
- ET-101
- Sham Device
-
Incheon, Korea, Republic ofGachon University Gil Medical Center
Jul 3, 2023
Presbyopia Trial in Crystal River (BRIMOCHOLâ„¢ PF, Carbachol PF, Vehicle)
Recruiting
- Presbyopia
- BRIMOCHOLâ„¢ PF
- +2 more
-
Chandler, Arizona
- +42 more
Sep 30, 2022
Participants Previously Treated With Century Therapeutics
Not yet recruiting
- Hematological Malignancy
- Solid Tumor Malignancy
- No Intervention
- (no location specified)
Mar 3, 2023
Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)
Active, not recruiting
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- TG-1701
- +2 more
-
East Melbourne, Victoria, Australia
- +7 more
Jan 20, 2023
Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- +3 more
-
Huntsville, Alabama
- +153 more
Aug 19, 2022
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Ublituximab, Ibrutinib)
Completed
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
-
Huntsville, Alabama
- +17 more
Oct 21, 2022
Pharmacodynamic Models of Chronic Disease Therapeutics for
Recruiting
- Chronic Disease
- Smoking
- Smoking
- non-somking
-
Chongqing, ChinaYu Xian
Dec 18, 2022
Nicotine Vaping, Nicotine Use Disorder Trial (quitSTART Mobile Application)
Not yet recruiting
- Nicotine Vaping
- Nicotine Use Disorder
- quitSTART Mobile Application
- (no location specified)
Aug 8, 2023
Cervical Spondylosis Trial in Lahore (Modified Cervical Retraction Exercises (MCRE), Motor Control therapeutic exercise(MCTE))
Recruiting
- Cervical Spondylosis
- Modified Cervical Retraction Exercises (MCRE)
- Motor Control therapeutic exercise(MCTE)
-
Lahore, Punjab, PakistanRiphah Rehabilitation Clinic
Jun 14, 2023
Tracking for the Developmental Therapeutics Clinic
Recruiting
- Neoplasms
- Lymphoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)
Terminated
- Diffuse Large B-Cell Lymphoma
- +4 more
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +167 more
Jul 20, 2022
Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)
Completed
- Pruritus
- Notalgia Paresthetica
- difelikefalin 2.0 mg
- Placebo
-
Fort Smith, Arkansas
- +35 more
Aug 1, 2022
Problem Behavior, Child Behavior Trial in Pittsburgh (UseIt! App, Coach, SmilingMind App)
Recruiting
- Problem Behavior
- Child Behavior
- UseIt! App
- +2 more
-
Pittsburgh, PennsylvaniaBellefield Towers
Dec 8, 2022
Generalized Anxiety Disorder Trial in Seoul (Software as a Medical device)
Recruiting
- Generalized Anxiety Disorder
- Software as a Medical device
-
Seoul, Korea, Republic ofYonsei University Health System, Gangnam Severance Hospital
Aug 20, 2023
Personalised Therapeutics @LUMC
Not yet recruiting
- Adverse Drug Reaction
- Genetic test for 14 pharmacogenes
- (no location specified)
Aug 18, 2022